On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayApr 16, 2021 2:14 pm

QualityStocksNewsBreaks – RYAH Group Inc.’s Products Facilitate Personalized Therapies, Remote Patient Monitoring

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, has created a range of smart devices set to disrupt the future of medicine. RYAH Group, which is on a mission to advance the world’s transition to remote-health solutions, has done precisely that with its remote health platform called RYAH MD. “RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with RYAH’s dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on…

Continue Reading

FridayApr 16, 2021 2:06 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Finalizes Move into US Cannabis Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, has closed a purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd. in which PACR will acquire all the issued and outstanding shares. Under the arrangement, Pac Roots agreed to pay $50,000 in cash, within 30 days of the closing date, and issue 6 million common shares of the company. Lords of Grasstown traces its origin to the vision of Tyler Hazelwood, the founder and director of the iconic Lords of Gastown brand. “This acquisition marks a major milestone for the company…

Continue Reading

FridayApr 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market

Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity in the fluid management systems and accessories market, which is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a CAGR of 13.6%. These figures are according MarketsandMarkets, which cites several growth factors including technological advancements in fluid management systems (https://ibn.fm/rKWZC). As disposal of waste fluids presents a unique set of challenges for every health care facility, Skyline Medical offers a clear solution. Skyline’s patented and FDA-cleared STREAMWAY System is “the new standard in waste fluid management,” automating the collection, measurement and…

Continue Reading

FridayApr 16, 2021 1:15 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) WP1244 Potentially 500X More Potent than Daunorubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company whose lead drug candidate Berubicin has yielded promising results in the treatment of glioblastoma multiforme (“GBM”), has made equally significant strides with its second drug candidate, WP1244. Still currently in development, preclinical work for WP1244 is expected to continue during 2021 and 2022. “WP1244 is a DNA-binding agent believed to be 500-times more potent than daunorubicin in inhibiting tumor cell proliferation,” reads a recent article. “The current target indication for WP1244 includes brain cancers, pancreatic cancers, ovarian cancers and lymphoma. Preclinical studies show high uptake in the brain with antitumor activity.” On the…

Continue Reading

FridayApr 16, 2021 1:08 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Eyes Q2 Expansion of Growing Portfolio

Healthy Extracts (OTCQB: HYEX) recently released its full-year 2020 report. In addition to achieving a 71% jump in its revenue on the back of a plant-based industry boom, the company announced it was at an advanced stage of clinical testing that would culminate in the release of a new product in Q2 2021. The proprietary Fuel4Thought Brain Booster product will add to Health Extracts’ portfolio, which has increased thanks to acquisitions. An article on the developments reads, “Healthy Extracts acquired BergaMet NA in 2019, engaged in selling and distributing a full line of proprietary formulations derived from the rare Citrus…

Continue Reading

FridayApr 16, 2021 12:54 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Leverages Niche to Offer Big Data and Value

SRAX (NASDAQ: SRAX), a financial technology company that unlocks insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has focused on offering big data to companies, as well as ensuring that they draw significant value from that data. SRAX’s efforts address an existing problem: today, most organizations struggle to get value from a lot of the data they have access to because, as a business practice, it is still very much in its infancy. “That’s where SRAX has carved a niche for itself,” reads an article regarding SRAX’s positioning. “Through Sequire, its innovative investor intelligence and communications platform,…

Continue Reading

FridayApr 16, 2021 12:34 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Featured in Research Report

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was featured in a research report by H.C. Wainwright & Co. The piece covers ongoing wellfield development and resource delineation drilling at UEC’s Burke Hollow in-situ recovery (“ISR”) uranium project in Texas, as well as its fully funded physical uranium initiative. “We are reiterating our Buy rating on UEC and our PT of $5. Our valuation remains based on a DCF of future operations for the firm, utilizing our recently revised 7.5% discount rate,” the report reads. “We then add an in-situ value of $75.0M for…

Continue Reading

FridayApr 16, 2021 12:14 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalization Mescaline has historically defied predictable outcomes by researchers, but advocates cite it as a means of successfully treating some mental health and substance abuse disorders A number of psychedelics production stocks saw huge gains during the past…

Continue Reading

FridayApr 16, 2021 12:00 pm

Ideanomics, Inc. (NASDAQ: IDEX) Evolving the Vision to Lead EV Solutions Development

New York-based Ideanomics redefined its operations last year to synergistically create a global ecosystem focused on the growing potential of the electric vehicle market Ideanomics expects its developing revenue stream to largely depend on a Sales to Financing to Charging (S2F2C) business model based on vehicle and battery sales, financing and insurance services, and EV battery charging and related energy services Forecasts anticipate more than a million global commercial EV sales by 2023 and growth in the global EV charging infrastructure market at a CAGR of 33.4 percent from 2021 to 2028 Global commercial electric vehicle company Ideanomics (NASDAQ: IDEX)…

Continue Reading

FridayApr 16, 2021 11:44 am

FingerMotion Inc. (FNGR) on Track to Monetize its Big Data Asset

FingerMotion Inc. is made up of four business units, including a big-data insights (Sapientus) division Sapientus is poised to be the company’s leading revenue generator, alongside the rich communication services division FingerMotion partnered with Pacific Life Re-insurance, ushering it into the insuratech industry wherein it can monetize its big-data asset with a sellable product MarketsandMarkets projects that the global big-data market size will grow to $229.4 billion by 2025, up from an estimated $138.9 billion in 2020. At a CAGR of 10.6%, this growth is driven by such factors as the increasing availability of data across organizations, knowledge of Internet…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered